BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36706615)

  • 1. Clonal hematopoiesis due to mosaic chromosomal alterations: Impact on disease risk and mortality.
    Hubbard AK; Brown DW; Machiela MJ
    Leuk Res; 2023 Mar; 126():107022. PubMed ID: 36706615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for clonal hematopoiesis of indeterminate potential and mosaic chromosomal alterations.
    Jakubek YA; Reiner AP; Honigberg MC
    Transl Res; 2023 May; 255():171-180. PubMed ID: 36414227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of smoking and risk of clonal hematopoiesis.
    Levin MG; Nakao T; Zekavat SM; Koyama S; Bick AG; Niroula A; Ebert B; Damrauer SM; Natarajan P
    Sci Rep; 2022 May; 12(1):7248. PubMed ID: 35508625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of mosaic chromosomal alteration fitness.
    Pershad Y; Mack T; Poisner H; Jakubek YA; Stilp AM; Mitchell BD; Lewis JP; Boerwinkle E; Loos RJF; Chami N; Wang Z; Barnes K; Pankratz N; Fornage M; Redline S; Psaty BM; Bis JC; Shojaie A; Silverman EK; Cho MH; Yun JH; DeMeo D; Levy D; Johnson AD; Mathias RA; Taub MA; Arnett D; North KE; Raffield LM; Carson AP; Doyle MF; Rich SS; Rotter JI; Guo X; Cox NJ; Roden DM; Franceschini N; Desai P; Reiner AP; Auer PL; Scheet PA; Jaiswal S; Weinstock JS; Bick AG
    Nat Commun; 2024 May; 15(1):3800. PubMed ID: 38714703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incident disease associations with mosaic chromosomal alterations on autosomes, X and Y chromosomes: insights from a phenome-wide association study in the UK Biobank.
    Lin SH; Brown DW; Rose B; Day F; Lee OW; Khan SM; Hislop J; Chanock SJ; Perry JRB; Machiela MJ
    Cell Biosci; 2021 Jul; 11(1):143. PubMed ID: 34301302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum biomarkers are altered in UK Biobank participants with mosaic chromosomal alterations.
    Hubbard AK; Brown DW; Zhou W; Lin SH; Genovese G; Chanock SJ; Machiela MJ
    Hum Mol Genet; 2023 Nov; 32(22):3146-3152. PubMed ID: 37565819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mosaic Chromosomal Alterations Are Associated With Increased Lung Cancer Risk: Insight From the INTEGRAL-ILCCO Cohort Analysis.
    Cheng C; Hong W; Li Y; Xiao X; McKay J; Han Y; Byun J; Peng B; Albanes D; Lam S; Tardon A; Chen C; Bojesen SE; Landi MT; Johansson M; Risch A; Bickeböller H; Wichmann HE; Christiani DC; Rennert G; Arnold S; Goodman G; Field JK; Davies MPA; Shete SS; Le Marchand L; Liu G; Hung RJ; Andrew AS; Kiemeney LA; Zhu M; Shen H; Zienolddiny S; Grankvist K; Johansson M; Cox A; Hong YC; Yuan JM; Lazarus P; Schabath MB; Aldrich MC; Brennan P; Li Y; Gorlova O; Gorlov I; Amos CI;
    J Thorac Oncol; 2023 Aug; 18(8):1003-1016. PubMed ID: 37150255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mosaic chromosomal alterations detected in men living with HIV and the relationship to non-Hodgkin lymphoma.
    Lin SH; Khan SM; Zhou W; Brown DW; Vergara C; Wolinsky SM; Martínez-Maza O; Margolick JB; Martinson JJ; Hussain SK; Engels EA; Machiela MJ
    AIDS; 2023 Jul; 37(8):1307-1313. PubMed ID: 36927626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis.
    Gao T; Ptashkin R; Bolton KL; Sirenko M; Fong C; Spitzer B; Menghrajani K; Ossa JEA; Zhou Y; Bernard E; Levine M; Martinez JSM; Zhang Y; Franch-Expósito S; Patel M; Braunstein LZ; Kelly D; Yabe M; Benayed R; Caltabellotta NM; Philip J; Paraiso E; Mantha S; Solit DB; Diaz LA; Berger MF; Klimek V; Levine RL; Zehir A; Devlin SM; Papaemmanuil E
    Nat Commun; 2021 Jan; 12(1):338. PubMed ID: 33436578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment.
    von Beck K; von Beck T; Ferrell PB; Bick AG; Kishtagari A
    Blood Cancer J; 2023 Jan; 13(1):5. PubMed ID: 36599826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinction of lymphoid and myeloid clonal hematopoiesis.
    Niroula A; Sekar A; Murakami MA; Trinder M; Agrawal M; Wong WJ; Bick AG; Uddin MM; Gibson CJ; Griffin GK; Honigberg MC; Zekavat SM; Paruchuri K; Natarajan P; Ebert BL
    Nat Med; 2021 Nov; 27(11):1921-1927. PubMed ID: 34663986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mosaic Chromosomal Alterations and Human Longevity.
    Leshchyk A; Xiang Q; Andersen SL; Gurinovich A; Song Z; Lee JH; Christensen K; Yashin A; Wojczynski M; Schwander K; Perls TT; Monti S; Sebastiani P
    J Gerontol A Biol Sci Med Sci; 2023 Aug; 78(9):1561-1568. PubMed ID: 36988570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of mosaic chromosomal alteration fitness.
    Pershad Y; Mack T; Poisner H; Jakubek YA; Stilp AM; Mitchell BD; Lewis JP; Boerwinkle E; Loos RJ; Chami N; Wang Z; Barnes K; Pankratz N; Fornage M; Redline S; Psaty BM; Bis JC; Shojaie A; Silverman EK; Cho MH; Yun J; DeMeo D; Levy D; Johnson A; Mathias R; Taub M; Arnett D; North K; Raffield LM; Carson A; Doyle MF; Rich SS; Rotter JI; Guo X; Cox N; Roden DM; Franceschini N; Desai P; Reiner A; Auer PL; Scheet P; Jaiswal S; Weinstock JS; Bick AG
    medRxiv; 2023 Oct; ():. PubMed ID: 37905118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal hematopoiesis, somatic mosaicism, and age-associated disease.
    Evans MA; Walsh K
    Physiol Rev; 2023 Jan; 103(1):649-716. PubMed ID: 36049115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the interaction between mosaic chromosomal alterations and polygenic risk score with the risk of lung cancer: an array-based case-control association and prospective cohort study.
    Qin N; Wang C; Chen C; Yang L; Liu S; Xiang J; Xie Y; Liang S; Zhou J; Xu X; Zhao X; Zhu M; Jin G; Ma H; Dai J; Hu Z; Shen H
    Lancet Oncol; 2022 Nov; 23(11):1465-1474. PubMed ID: 36265503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic mosaic chromosomal alterations increase the risk for diverse types of infection.
    Zekavat SM; Lin SH; Bick AG; Liu A; Paruchuri K; Wang C; Uddin MM; Ye Y; Yu Z; Liu X; Kamatani Y; Bhattacharya R; Pirruccello JP; Pampana A; Loh PR; Kohli P; McCarroll SA; Kiryluk K; Neale B; Ionita-Laza I; Engels EA; Brown DW; Smoller JW; Green R; Karlson EW; Lebo M; Ellinor PT; Weiss ST; Daly MJ; ; ; Terao C; Zhao H; Ebert BL; Reilly MP; Ganna A; Machiela MJ; Genovese G; Natarajan P
    Nat Med; 2021 Jun; 27(6):1012-1024. PubMed ID: 34099924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal Hematopoiesis: Origins and determinants of evolution.
    Mendez LM; Patnaik MM
    Leuk Res; 2023 Jun; 129():107076. PubMed ID: 37075557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shared and distinct genetic etiologies for different types of clonal hematopoiesis.
    Brown DW; Cato LD; Zhao Y; Nandakumar SK; Bao EL; Gardner EJ; Hubbard AK; DePaulis A; Rehling T; Song L; Yu K; Chanock SJ; Perry JRB; Sankaran VG; Machiela MJ
    Nat Commun; 2023 Sep; 14(1):5536. PubMed ID: 37684235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal Hematopoiesis and the Heart: a Toxic Relationship.
    Jensen JL; Easaw S; Anderson T; Varma Y; Zhang J; Jensen BC; Coombs CC
    Curr Oncol Rep; 2023 May; 25(5):455-463. PubMed ID: 36920637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation risk.
    Kishtagari A; Khan MAW; Li Y; Vlasschaert C; Marneni N; Silver AJ; von Beck K; Spaulding T; Stockton S; Snider C; Sochacki A; Dorand D; Mack TM; Ferrell PB; Xu Y; Bejan CA; Savona MR; Bick AG
    Blood Cancer J; 2024 Jan; 14(1):6. PubMed ID: 38225345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.